An Essential Role of NRF2 in Diabetic Wound Healing
Top Cited Papers
Open Access
- 30 December 2015
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 65 (3), 780-793
- https://doi.org/10.2337/db15-0564
Abstract
The high mortality and disability of diabetic nonhealing skin ulcers create an urgent need for the development of more efficacious strategies targeting diabetic wound healing. In the current study, using human clinical specimens, we show that perilesional skin tissues from patients with diabetes are under more severe oxidative stress and display higher activation of the nuclear factor-E2–related factor 2 (NRF2)–mediated antioxidant response than perilesional skin tissues from normoglycemic patients. In a streptozotocin-induced diabetes mouse model, Nrf2−/− mice have delayed wound closure rates compared with Nrf2+/+ mice, which is, at least partially, due to greater oxidative DNA damage, low transforming growth factor-β1 (TGF-β1) and high matrix metalloproteinase 9 (MMP9) expression, and increased apoptosis. More importantly, pharmacological activation of the NRF2 pathway significantly improves diabetic wound healing. In vitro experiments in human immortalized keratinocyte cells confirm that NRF2 contributes to wound healing by alleviating oxidative stress, increasing proliferation and migration, decreasing apoptosis, and increasing the expression of TGF-β1 and lowering MMP9 under high-glucose conditions. This study indicates an essential role for NRF2 in diabetic wound healing and the therapeutic benefits of activating NRF2 in this disease, laying the foundation for future clinical trials using NRF2 activators in treating diabetic skin ulcers.Keywords
Funding Information
- State Scholarship Fund of China (201207610022)
- Chongqing Science Foundation (cstc2013jcsfC10001-5)
- National Cancer Institute (R21CA166926, R01 CA154377)
- National Natural Science Foundation of China (81228023, 81471039)
- National Institute of Environmental Health Sciences (R01 ES015010, ES006694)
This publication has 55 references indexed in Scilit:
- The Nrf2-inducers tanshinone I and dihydrotanshinone protect human skin cells and reconstructed human skin against solar simulated UVRedox Biology, 2013
- Nrf2 Is Crucial to Graft Survival in a Rodent Model of Heart TransplantationOxidative Medicine and Cellular Longevity, 2013
- Cell crawling mediates collective cell migration to close undamaged epithelial gapsProceedings of the National Academy of Sciences of the United States of America, 2012
- Inhibitor of Nrf2 (INrf2 or Keap1) Protein Degrades Bcl-xL via Phosphoglycerate Mutase 5 and Controls Cellular Apoptosis*Published by Elsevier BV ,2011
- Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic NephropathyDiabetes, 2011
- A Noncanonical Mechanism of Nrf2 Activation by Autophagy Deficiency: Direct Interaction between Keap1 and p62Molecular and Cellular Biology, 2010
- Increased cell migration and plasticity in Nrf2-deficient cancer cell linesOncogene, 2010
- The Nrf2–ARE PathwayAnnals of the New York Academy of Sciences, 2008
- Hyperglycaemic conditions decrease cultured keratinocyte mobility: implications for impaired wound healing in patients with diabetesBritish Journal of Dermatology, 2008
- Nrf Transcription Factors in Keratinocytes Are Essential for Skin Tumor Prevention but Not for Wound HealingMolecular and Cellular Biology, 2006